StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
ETRAElectra Therapeutics, Inc.
stockpulse.co.kr
Nasdaq
$8.71▼ 0.68%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

12
  • 9.29Overnight26.09.29 10:00
    SCHEDULE 13GOwnership#●●●#●●●

    Electra Therapeutics, Inc.

    Redmile Group, LLC and affiliated investment entities have filed a joint Schedule 13G regarding their ownership of Electra Therapeutics, Inc. common stock. This filing formalizes the joint holding of the company's shares by these investors.…more

    $8.71-0.68%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 9.29Overnight26.09.29 10:00
    SCHEDULE 13GOwnership

    Electra Therapeutics, Inc.

    LSP 7 Cooperatief U.A. has filed a Schedule 13G, reporting a beneficial ownership of more than 5% in Electra Therapeutics, Inc. This filing serves as an official disclosure of the investor's significant stake in the company.…more

    $8.71-0.68%vs prev close
    View filingShare
  • 9.25After-hours26.09.26 06:11
    SCHEDULE 13DOwnership

    Electra Therapeutics, Inc.

    OrbiMed Advisors LLC and its affiliates filed a Schedule 13D regarding their ownership of Electra Therapeutics, Inc. common stock on September 21, 2026. This filing formalizes the joint agreement for the reporting and management of their equity stake in the company.…more

    $8.71-0.68%vs prev close
    View filingShare

11 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire
  • 2d agoPre-market26.10.23 20:03
    #●●●#●●●

    Star Therapeutics Secures $200M in Private Financing

    Star Therapeutics has successfully raised $200 million in private financing to advance its next-generation pipeline and move preclinical programs into clinical trials. The capital will support the expansion of its therapeutic programs and the development of potential best-in-disease treatments.…more

    $8.71-0.68%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    ShareBenzinga
  • 9.18Regular26.09.18 23:47

    ●●●●●●●● ●●●●● ●●●●●●

    Electra Therapeutics has priced its initial public offering at $15.00 per share for 23.33 million shares. Market indicators suggest the stock may trade around $19.00 following the offering.…more

    $8.71-0.68%vs prev close
    ShareBenzinga
  • 9.18Regular26.09.18 23:35

    ●●●●●●●● ●●●●● ●●●●●●

    The trading halt for the newly listed security has been lifted as of 10:35 AM ET. Investors should monitor the market price as trading resumes.…more

    $8.71-0.68%vs prev close
    ShareBenzinga

2 more news items

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →